Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis
Samuel Hawley(University of Bristol), Daniel Prieto‐Alhambra(Nuffield Orthopaedic Centre), Antonella Delmestri(University of Oxford), Nigel Arden(Nuffield Orthopaedic Centre), Andrew Judge(Royal College of Obstetricians and Gynaecologists), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Lene Dreyer(Institute for Rheumatic Diseases (Japan)), René Cordtz(Gentofte Hospital), Cyrus Cooper(University Hospital Southampton NHS Foundation Trust), Alan J. Silman(Nuffield Orthopaedic Centre)
Cited by 27
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k